Group B Streptococcus (GBS) in the urinary tract causes symptoms similar to other urinary tract infections (UTIs), including painful urination, urgency, and cloudy or foul-smelling urine. GBS uti symptoms are not unique to the bacteria but result from inflammation and irritation in the bladder or urethra.
GBS is a common bacterium found in the digestive, genital, and urinary tracts of healthy adults. While it often causes no symptoms, when it colonizes the urinary tract, it can lead to symptomatic infection. The presence of GBS in urine during pregnancy raises concern because it increases the risk of neonatal infection during delivery.
According to the Centers for Disease Control and Prevention (CDC), approximately 25% of pregnant women carry GBS in their rectum or vagina. When GBS enters the urinary system, it may trigger a localized immune response, resulting in classic UTI signs. However, unlike typical UTIs caused by E. coli, GBS UTIs require specific treatment due to resistance patterns and potential complications.
GBS uti symptoms arise when Group B Streptococcus multiplies in the urinary tract, particularly the bladder. The bacteria adhere to uroepithelial cells lining the bladder wall, triggering inflammation. This leads to increased sensitivity and pain during urination, a condition known as dysuria.
The immune system responds by sending white blood cells to the site of infection. These cells release chemicals that cause swelling and irritation, contributing to the sensation of needing to urinate frequently-even when little urine is produced. This is called frequency and is a sign symptom of lower UTIs.
A clinical study published in *The Journal of Infectious Diseases* found that 68% of women with GBS-positive urine cultures reported dysuria and frequency. Symptoms typically appear within 24-72 hours of bacterial colonization and worsen without treatment. Left untreated, GBS can ascend into the kidneys, leading to pyelonephritis-a serious complication requiring hospitalization.
GBS uti symptoms overlap with those of other UTIs. However, certain patterns help distinguish them clinically. The following table outlines key differences between GBS UTI and typical E. coli UTI:
| Symptom | GBS UTI Frequency | Typical E. coli UTI Frequency |
|---|---|---|
| Burning during urination | 72% | 81% |
| Frequent urge to urinate | 65% | 78% |
| Cloudy or strong-smelling urine | 59% | 67% |
| Lower abdominal pain | 44% | 52% |
| Fever above 100.4°F | 12% | 29% |
Data from the CDC's National Healthcare Safety Network (NHSN) shows that GBS UTIs are less likely to present with systemic signs like fever compared to E. coli infections. This difference can delay diagnosis, especially in asymptomatic carriers.
One non-obvious distinction: GBS UTIs are more likely to recur in the same individual. A 2021 study in *Clinical Microbiology and Infection* found that women who had a GBS UTI were 2.3 times more likely to have a recurrence within six months than those with E. coli UTIs. This suggests GBS may persist in the genitourinary tract despite initial treatment.
GBS uti symptoms most commonly affect pregnant women. The American College of Obstetricians and Gynecologists (ACOG) recommends universal screening for GBS at 35-37 weeks of gestation. If a woman tests positive, she receives intravenous antibiotics during labor to prevent transmission to the newborn.
During pregnancy, hormonal changes and physical pressure from the growing uterus slow urine flow and increase residual volume in the bladder. This environment favors bacterial growth. GBS can travel from the rectum or vagina into the urethra through hand-to-genital contact or sexual activity.
I observed this firsthand while working in a prenatal clinic. A patient at 36 weeks reported burning during urination and a constant urge to go. Urinalysis showed leukocyte esterase and nitrites. Culture confirmed GBS. She was treated with ampicillin and delivered a healthy baby without infection. Her symptoms resolved in 48 hours.
Many assume that GBS uti symptoms are always severe or accompanied by fever. This is incorrect. GBS UTIs often present with mild or absent systemic symptoms. A woman may report only discomfort during urination and no fever, which can lead to underdiagnosis.
Another misconception is that GBS in urine always requires treatment. According to ACOG guidelines, asymptomatic GBS bacteriuria during pregnancy should be treated. The risk of ascending infection and neonatal sepsis outweighs the side effects of antibiotics. Treatment reduces the chance of early-onset GBS disease in newborns by 80%.
Some patients confuse GBS uti symptoms with yeast infections. Yeast infections cause intense itching and thick, white discharge, not burning during urination. GBS UTI symptoms do not include vaginal itching or abnormal discharge. Misdiagnosis can delay proper treatment.
If you experience persistent burning, urgency, or cloudy urine during pregnancy, see a healthcare provider. Diagnosis begins with a urine dipstick test. Positive results for leukocyte esterase and nitrites suggest infection. Confirmation requires a urine culture.
GBS is identified using selective media such as Granada medium or chromogenic agar. The bacteria grow as beta-hemolytic colonies with a characteristic greenish halo. A count of ≥10⁵ CFU/mL confirms infection.
For pregnant women, treatment is standard. Oral antibiotics like amoxicillin or ampicillin are first-line options. If the patient is allergic, alternatives include clindamycin or vancomycin. Treatment duration is typically 7 days. After treatment, a follow-up urine culture ensures eradication.
GBS uti symptoms are not rare. They represent a significant risk during pregnancy and require prompt attention. Recognizing the signs-especially in the absence of fever-can prevent complications for both mother and baby.